The University of Alabama at Birmingham Receives $5.8 Million in Funding from PCORI to Assess Effectiveness of Multiple Sclerosis Treatment
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors has approved funding for a $5.8 million multiple sclerosis (MS) study in Birmingham, AL.
Led by a research team at the University of Alabama in Birmingham, the trial will compare the effects of delivering an exercise-based rehabilitation program via Internet or telephone versus providing the therapy in a clinic. Evidence shows that exercise, yoga, and other such therapies can alleviate symptoms and improve functions, but clinics that can provide such services are scarce in rural and low-income areas.
The study is one of four addressing MS therapies, all of which are underwritten by nearly $20 million in PCORI funding. All four studies will be designed and conducted with significant input from patients, family caregivers, and other healthcare stakeholders. Each will include people with MS; nurses, physicians or other clinicians; or representatives of other stakeholder groups on their research teams.
“PCORI is delighted to make these new awards addressing crucial evidence gaps and questions of vital interest to the more than 400,000 people in the U.S. living with multiple sclerosis,” said PCORI Executive Director Joe Selby, MD, MPH. “These studies will provide significant new evidence to help patients, their families and their clinicians decide more confidently which of the therapies available to them will work best given their needs and preferences.”
Study participants are being recruited in Alabama and Mississippi. For more information, please contact Whitney Neal, Project Coordinator, at (205) 403-5511 or firstname.lastname@example.org.
This work is supported through a Patient-Centered Outcomes Research Institute (PCORI) Award #MS – 1511 – 33653.